The stock performs 2.5 times better than the Nifty 500 index, demonstrating strong relative strength. This implies that, in contrast to the overall market, the stock is resilient and has room to rise. When analysing the stock's performance over different time periods, it shows remarkable gains: 53.43 per cent over the last three months, 285.98 per cent over the previous year, and a multibagger return of 1376.68 per cent over the previous three years. These gains suggest that the market is still bullish and that there are good chances for future price growth.

On February 08, 2024, foreign institutional investors (FII) offloaded shares worth Rs 4,933.78 crore, while domestic institutional investors (DII) purchased shares worth Rs 5,512.32 crore.

The combined taxes paid by both companies on a trailing twelve-month basis amount to Rs 43,351 crore, representing approximately 4.16 per cent of the total corporate tax revenue figure reported in the recent budget.

At the start of the year, the company has found itself at the center of attention as 25 entities, including notable names like Sheth Developers and Sunteck Realty, have expressed keen interest in acquiring the beleaguered company, which has been mired in bankruptcy proceedings.

Our country is still the fastest-growing major economy in the world, and there is a world of opportunities available for fintechs to continue their growth and scale even faster, affirms Vishwas Patel, Joint Managing Director, Infibeam Avenues Ltd.

In this landscape of innovation, companies like Laurus Lab Ltd stand out as key players driving progress in the transformative cell and gene therapy space. Their strategic collaborations and advancements in product development hold promise for improving treatment outcomes and enhancing accessibility for patients

The stock is down by 10 per cent from its 52-week high of Rs 84 while the stock is up by 33.71 per cent from its 52-week low of Rs 56.84.

The broader market sentiment remains negative, with 366 stocks advancing compared to 1,960 declining, reflecting an overall optimistic trend in the market.

Stock has demonstrated stellar returns, delivering multibagger gains of 143.09 per cent over the past year and an impressive surge of 224.35 per cent over the last three years. This performance underscores the company's strong growth trajectory and investor confidence in its prospects